laboratory spotlight: bioburden testing and considerations

December 20, 2021

We are pleased to share our most recent Testing Services TechTip, focusing on bioburden testing and considerations. This new TechTip joins our existing comprehensive library of technical resources for sterilization and laboratory testing.

What is Bioburden?

Bioburden is the quantity and types of native bacterial and fungal flora present on or in a device, substrate, or chemical.

The Importance of Bioburden Control:

Bioburden control is key to a successful sterilization validation and ongoing routine operations. Bioburden testing is important not only in determining the microbiological quality or cleanliness of a finished product, but can also be critical to the dose used for some methods of sterilization.

A higher bioburden count can lead to:

  • Greater sterilization process challenges
  • The more resistant the bioburden is, the increased probability of longer sterilization times or higher dose, and more difficult comparative resistance becomes in sterilization validation
  • The greater the probability of significant levels of toxins or deleterious effects to the product

STERIS:

At STERIS, our bioburden testing is developed and validated for each individual product or device type and testing is performed in accordance with ISO 11737-1 for terminally sterilized medical devices. Our bioburden testing ensures the best accuracy and repeatability, and each method is designed to best suit our Customers’ specific needs. Controlled testing documentation is issued to Customers for every bioburden method developed, ensuring consistency in testing throughout product/device life span and product warnings and/or alert limits are included in individual bioburden methods.

Contact us today to discuss your individual project requirements.

Rebecca-Dish-300x212

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. For more information, visit www.steris.com.

 
Related Posts
Exterior View of STERIS Facility in Batu Kawan, Malaysia
May 1, 2025

As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce a new ethylene oxide (EO) processing facility in Batu Kawan industrial Park in Penang, Malaysia.

202310-LibertyvilleIL-Lab-5
March 28, 2025
March 28, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce the addition of Extractables and Leachables (E&L) testing, featuring advanced chemical analysis.
New-Swindon-Lab-1-600x600
February 5, 2025
February 5, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our South Marston, UK laboratory has relocated to Swindon, UK. The new laboratory supports the increased demand in volume and complexity of medical devices and pharmaceuticals in the region.
STERIS is pleased to announce our brooklyn park mn usa laboratory now offers bacteria
January 10, 2025
January 10, 2025 – As part of our long-term commitment to supporting global healthcare product manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory now offers a sustainable approach to bacterial endotoxin testing through the use of recombinant cascade reagents.